Online citations, reference lists, and bibliographies.
← Back to Search

Radiology In Pleural Disease: What Is The Role Of Chest Radiographs, CT And PET In Modern Management?

Laura Duerden, R. Benamore, A. Edey
Published 2020 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1136/thx.36.9.669
Non-malignant asbestos pleural disease.
G. Hillerdal (1981)
10.1136/thoraxjnl-2014-206054
Role of CT in assessing pleural malignancy prior to thoracoscopy
R. J. Hallifax (2014)
10.1016/J.CRAD.2006.06.008
Benign localized fibrous tumour of the pleura: CT features with histopathological correlations.
S. Chong (2006)
10.1259/bjr.20150792
Focal pleural thickening mimicking pleural plaques on chest computed tomography: tips and tricks.
Khalid M Alfudhili (2016)
10.1007/s003300050984
Evaluation of CT findings for diagnosis of pleural effusions
J. Arenas-Jiménez (2000)
10.1016/S0954-6111(06)80080-6
Assessment of asbestos-induced pleural disease by computed tomography--correlation with chest radiograph and lung function.
N. al Jarad (1991)
10.1016/J.CRAD.2006.02.004
Prevalence and clinical significance of pleural microbubbles in computed tomography of thoracic empyema.
A. Smolikov (2006)
10.1378/CHEST.118.3.604
MRI and CT in the differential diagnosis of pleural disease.
J. Hierholzer (2000)
10.1002/cam4.1182
Prognostic and predictive role of [18F]fluorodeoxyglucose positron emission tomography (FDG‐PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up‐front pemetrexed‐based chemotherapy
P. Zucali (2017)
10.2214/AJR.169.2.9242783
Lipoma and liposarcoma: evaluation using CT and MR imaging.
P. Munk (1997)
10.1007/s00259-013-2561-1
The association of 18F-FDG PET/CT parameters with survival in malignant pleural mesothelioma
A. Klabatsa (2013)
10.1111/j.1553-2712.2009.00628.x
Sensitivity of bedside ultrasound and supine anteroposterior chest radiographs for the identification of pneumothorax after blunt trauma.
R. G. Wilkerson (2010)
10.1002/1097-0142(19940201)73:3<738::AID-CNCR2820730339>3.0.CO;2-6
Pyothorax‐associated pleural lymphoma. A case evolving from T‐cell‐rich lymphoid infiltration to overt B‐cell lymphoma in association with Epstein‐Barr virus
T. Ibuka (1994)
10.1007/s00259-014-2960-y
Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma
E. Lopci (2014)
10.2214/AJR.159.5.1414807
Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability.
E. Patz (1992)
10.1053/CRAD.1999.0480
Computed tomography and ultrasound in parapneumonic effusions and empyema.
S. Kearney (2000)
10.1016/0002-9610(91)90199-N
Value of computed tomography of the lung in the management of primary spontaneous pneumothorax.
B. Warner (1991)
10.1378/chest.14-0196
Pulmonary changes of pleural TB: up-to-date CT imaging.
J. M. Ko (2014)
10.1007/s00259-010-1704-x
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival
V. Gerbaudo (2010)
10.1016/J.CTRV.2007.10.001
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy.
M. A. Pantaleo (2008)
10.1177/0284185113513894
Chest CT findings of pleural tuberculosis: differential diagnosis of pleural tuberculosis and malignant pleural dissemination
Jin Sil Kim (2014)
10.1159/000347003
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
C. Hooper (2013)
10.1016/J.ACRA.2005.05.002
Accuracy of computed tomography attenuation values in the characterization of pleural fluid: an ROC study.
K. Nandalur (2005)
10.2214/AJR.11.7015
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
R. Gill (2012)
10.1007/s00259-019-04287-7
Development and validation of the PET-CT score for diagnosis of malignant pleural effusion
M. Yang (2019)
10.1053/CRAD.2000.0573
Thoracic computed tomography in patients with suspected malignant pleural effusions.
Z. Traill (2001)
10.1007/s11604-010-0484-3
Malignant solitary fibrous tumor of the pleura: computed tomography-pathological correlation and comparison with computed tomography of benign solitary fibrous tumor of the pleura
S. W. Song (2010)
10.1016/S0022-5223(19)35312-7
The role of computed tomography scanning in the initial assessment and the follow-up of malignant pleural mesothelioma.
V. Rusch (1988)
10.1148/radiol.2018181567
Dual-Energy CT-derived Iodine Maps: Use in Assessing Pleural Carcinomatosis.
S. Lennartz (2019)
10.1148/RADIOLOGY.220.1.R01JL27237
Functional consequences of pleural disease evaluated with chest radiography and CT.
S. J. Copley (2001)
[Comparison of computerized tomography and magnetic resonance in the assessment of benign and malignant pleural diseases].
F. Falaschi (1996)
10.1183/2312508x.10023819
Effusions related to TB
J. Shaw (2020)
10.1148/RADIOLOGY.192.3.8058951
Pleural exudates and transudates: diagnosis with contrast-enhanced CT.
S. Aquino (1994)
10.1016/j.ejca.2008.10.026
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E. Eisenhauer (2009)
10.1148/RADIOLOGY.213.2.R99NV08553
The comet tail sign.
V. Partap (1999)
10.1016/j.lungcan.2016.01.017
Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma.
K. Martini (2016)
10.1378/chest.12-0364
Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study.
A. Reissig (2012)
10.1016/j.lungcan.2014.11.019
Radiologic-pathologic correlation of mesothelioma tumor volume.
S. Armato (2015)
10.1093/ANNONC/MDH059
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma.
M. Byrne (2004)
10.1016/j.cllc.2018.08.019
Moderately Hypofractionated Helical IMRT, FDG–PET/CT‐guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs
A. Fodor (2019)
10.1097/RLU.0b013e3181bece11
F-18 FDG PET/CT Characterization of Talc Pleurodesis-Induced Pleural Changes Over Time: A Retrospective Study
N. Nguyen (2009)
10.1148/RG.233025165
From the archives of the AFIP: Localized fibrous tumor of the pleura.
M. Rosado-de-Christenson (2003)
10.1371/journal.pone.0193714
Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT
Xirong Zhang (2018)
10.1016/j.crad.2009.03.010
CT appearances of pleural tumours.
H. Salahudeen (2009)
10.1016/J.EJRAD.2019.04.003
Loco-regional staging of malignant pleural mesothelioma by integrated 18F-FDG PET/MRI.
D. Murphy (2019)
10.1148/radiol.2015142631
Dual- and Multi-Energy CT: Principles, Technical Approaches, and Clinical Applications.
C. McCollough (2015)
10.1016/j.diii.2012.01.011
Focal dependent pleural thickening at MDCT: pleural lesion or functional abnormality?
M. Claude-Desroches (2012)
10.1007/s11307-009-0203-6
Prognostic Value of 18F-FDG PET/CT in Patients with Malignant Pleural Mesothelioma
S. Lee (2009)
10.1097/00004728-200303000-00029
Posterior Subpleural Nodules in Patients With Underlying Malignancies: Value of Prone Computed Tomography
J. Goo (2003)
10.1378/CHEST.125.6.2356
Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis.
B. H. Kwek (2004)
10.1016/j.rmed.2017.02.013
State-of-the-art: Radiological investigation of pleural disease.
R. Hallifax (2017)
10.1016/j.athoracsur.2008.03.052
Intrathoracic lipomas: their clinicopathological behaviors are not as straightforward as expected.
H. Sakurai (2008)
10.1016/j.jtho.2016.09.124
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
V. Rusch (2016)
10.1007/s11604-016-0555-1
Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma
K. Kitajima (2016)
10.1111/j.1440-1843.2011.02059.x
Novel molecular imaging in lung and pleural diseases
R. Francis (2011)
10.1183/09031936.00063109
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel (2009)
10.1016/j.jtho.2018.04.034
Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1)
S. Armato (2018)
10.1200/JCO.2006.06.8999
Early Response Evaluation in Malignant Pleural Mesothelioma by Positron Emission Tomography With [18F]Fluorodeoxyglucose
G. Ceresoli (2006)
10.1148/RADIOL.2431041658
The split pleura sign.
G. J. Kraus (2007)
10.1148/RADIOLOGY.166.3.3340770
Asbestos-related pleural and parenchymal fibrosis: detection with high-resolution CT.
D. Aberle (1988)
10.1148/74.1.36
Recognition of infrapulmonary pleural effusion.
J. A. Petersen (1960)
10.2214/AJR.154.3.2106209
CT in differential diagnosis of diffuse pleural disease.
A. Leung (1990)
10.1183/09031936.00000211
Predictive factors, microbiology and outcome of patients with parapneumonic effusion
M. Falguera (2011)
10.1378/CHEST.129.3.545
COPD can mimic the appearance of pneumothorax on thoracic ultrasound.
A. Slater (2006)
10.1148/RADIOLOGY.171.1.2928515
Costal pleura: appearances at high-resolution CT.
J. Im (1989)
10.1148/RADIOGRAPHICS.22.SUPPL_1.G02OC10S167
Asbestos: when the dust settles an imaging review of asbestos-related disease.
H. Roach (2002)
10.2214/AJR.169.1.9207506
CT appearance of the pleural space after talc pleurodesis.
J. G. Murray (1997)
10.2214/AJR.172.4.10587144
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
R. Heelan (1999)
10.1259/bjr.20170218
The physiological consequences of different distributions of diffuse pleural thickening on CT imaging.
D. de Fonseka (2017)
10.2214/AJR.142.1.59
Recognition of pleural effusion on supine radiographs: how much fluid is required?
J. Woodring (1984)
10.1016/J.CRAD.2005.05.015
Use of imaging in the management of malignant pleural mesothelioma.
R. Benamore (2005)
10.1148/RADIOLOGY.186.2.8421723
Imaging of the pleura.
N. Müller (1993)
10.1111/resp.12675
Diagnostic value of radiological imaging pre‐ and post‐drainage of pleural effusions
J. Corcoran (2016)
10.1016/S0003-4975(01)03374-4
Solitary fibrous tumors of the pleura.
M. D. de Perrot (2002)
10.1053/j.ro.2013.03.017
Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations.
M. Truong (2013)
10.1016/j.lungcan.2016.11.010
The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy
S. Tsim (2017)
10.1183/09031936.98.11051021
Asbestosis, pleural plaques and diffuse pleural thickening: three distinct benign responses to asbestos exposure.
P. A. Gevenois (1998)
10.1513/AnnalsATS.201509-584OC
Lung Parenchymal Assessment in Primary and Secondary Pneumothorax.
Oliver J. Bintcliffe (2016)
10.1136/thorax.58.12.1077
Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma
V. Gerbaudo (2003)
10.1148/RADIOLOGY.175.1.2315473
Parietal pleural changes in empyema: appearances at CT.
R. J. Waite (1990)
10.1016/J.ARBRES.2013.11.007
Etiología del derrame pleural: análisis de más de 3.000 toracocentesis consecutivas
J. M. Porcel (2014)
10.1378/CHEST.118.2.380
Can CT scanning be used to select patients with unilateral primary spontaneous pneumothorax for bilateral surgery?
A. Sihoe (2000)
10.1097/MCP.0000000000000485
Chest imaging for the diagnosis of complicated parapneumonic effusions
J. M. Porcel (2018)
10.1378/chest.14-0820
Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: a meta-analysis.
J. M. Porcel (2015)
10.1259/bjr.20170814
18F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center.
H. S. Elliott (2018)
10.1148/RADIOL.2362041363
Pleural disease in silicosis: pleural thickening, effusion, and invagination.
H. Arakawa (2005)
10.1007/s13244-016-0486-5
Demystifying the persistent pneumothorax: role of imaging
A. Chaturvedi (2016)
10.1259/bjr/55980445
Multidetector CT imaging of pleura: comparison of two contrast infusion protocols.
V. Raj (2011)
10.1016/j.acra.2013.09.015
Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
G. Treglia (2014)
10.1371/journal.pone.0130141
A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT
Naoki Tsujimoto (2015)
10.1111/j.1440-1843.2005.00715.x
Factors related to recurrence of spontaneous pneumothorax
Y. Guo (2005)
10.1097/JTO.0b013e3182653d64
Malignant Solitary Fibrous Tumors of the Pleura: Retrospective Review of a Multicenter Series
F. Lococo (2012)
10.1378/CHEST.74.2.170
The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia.
D. A. Taryle (1978)
10.1245/s10434-010-1107-z
Volume-Based Parameter of 18F-FDG PET/CT in Malignant Pleural Mesothelioma: Prediction of Therapeutic Response and Prognostic Implications
H. Lee (2010)
10.1136/bmj.330.7506.1493
Radiological review of pneumothorax
A. O'connor (2005)
10.1016/j.jtho.2016.09.121
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
D. Rice (2016)
10.1016/S0720-048X(00)00168-6
Malignant pleural disease.
B. Feragalli (2003)
10.1148/RADIOGRAPHICS.9.3.2727359
Conventional and high resolution computed tomography in the diagnosis of asbestos-related diseases.
D. Lynch (1989)
10.1016/J.CRAD.2006.10.007
CT appearances of talc pleurodesis.
S. Narayanaswamy (2007)
10.1148/radiol.2462070712
Fleischner Society: glossary of terms for thoracic imaging.
D. Hansell (2008)
10.1016/0899-7071(91)90156-P
Localized fibrous pleural mesothelioma: CT findings.
D. Mendelson (1991)
10.2214/AJR.150.2.269
Asbestos-related pleural disease and asbestosis: a comparison of CT and chest radiography.
A. Friedman (1988)
10.1183/2312508x.10023219
Thoracic ultrasound: a key tool beyond procedure guidance
R. Banka (2020)
10.1148/RADIOLOGY.169.3.3186982
Asbestos-related focal lung masses: manifestations on conventional and high-resolution CT scans.
D. Lynch (1988)
10.1148/RADIOLOGY.136.1.7384513
The deep sulcus sign.
R. Gordon (1980)
10.1016/j.crad.2017.03.028
Solitary fibrous tumour of pleura: CT differentiation of benign and malignant types.
A. Gupta (2017)
10.1378/chest.14-0013
Derivation and validation of a CT scan scoring system for discriminating malignant from benign pleural effusions.
J. M. Porcel (2015)
10.1016/J.EJCTS.2007.05.027
Diagnosis, treatment and long-term outcome of solitary fibrous tumours of the pleura.
M. Kohler (2007)
10.1148/RG.241035058
Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.
Z. Wang (2004)
10.1378/CHEST.90.2.265
Pleural lipoma. Diagnosis by computed tomography.
G. Epler (1986)
10.1016/S0009-9260(05)81459-X
Primary malignant localized fibrous tumours of the pleura: clinical, radiological and pathological features.
A. Saifuddin (1992)
10.1259/bjr.20180254
Early and delayed phases of contrast-enhanced CT for evaluating patients with malignant pleural effusion. Results of pairwise comparison by multiple observers.
J. Arenas-Jiménez (2018)
10.1016/j.lungcan.2013.11.002
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the assessment of pleural abnormalities in cancer patients: a systematic review and a meta-analysis.
G. Treglia (2014)
10.1136/bmjresp-2017-000266
BTS guideline for the investigation and management of malignant pleural mesothelioma
I. Woolhouse (2018)
10.1148/RADIOGRAPHICS.6.1.3685482
Ascites or pleural effusion? CT differentiation: four useful criteria.
R. Halvorsen (1986)
10.1183/09031936.97.10051150
Parapneumonic effusion and empyema.
H. Hamm (1997)
10.1007/s13244-015-0441-x
Imaging characteristics of pleural tumours
L. De Paoli (2015)
10.2214/AJR.144.1.9
Diffuse pleural thickening in an asbestos-exposed population: prevalence and causes.
T. Mcloud (1985)
10.2214/AJR.141.1.163
Differentiating lung abscess and empyema: radiography and computed tomography.
David D. Stark (1983)
10.1183/2312508x.10023719
Pleural infection: moving from treatment to prevention
E. Bedawi (2020)
10.1016/j.jtho.2016.08.147
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
A. Nowak (2016)
10.1016/S2213-2600(15)00220-9
Spontaneous pneumothorax: time to rethink management?
O. Bintcliffe (2015)
10.1016/S0720-048X(01)00426-0
Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural diseases.
M. Metintas (2002)
10.1148/rg.2017160180
Multidetector CT for Evaluation of the Extrapleural Space.
M. Santamarina (2017)
10.1016/j.acra.2017.03.006
Can CT and MR Shape and Textural Features Differentiate Benign Versus Malignant Pleural Lesions?
Elena Peña (2017)
Prognostic value of FDG PET imaging in malignant pleural mesothelioma.
D. C. Ng (2000)
10.1016/j.crad.2018.07.093
Pleural tumours and tumour-like lesions.
F. Aluja Jaramillo (2018)
10.2214/AJR.08.1286
Pleural effusion: characterization with CT attenuation values and CT appearance.
Yigal Abramowitz (2009)
10.2214/AJR.158.5.1566702
CT findings in benign fibrous mesothelioma of the pleura: pathologic correlation in nine patients.
K. Lee (1992)
10.3816/CLC.2009.n.033
Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
Brad E Wilcox (2009)



Semantic Scholar Logo Some data provided by SemanticScholar